KEAP1 and hepatocellular carcinoma: In this regard, it is interesting to note that K67, a small noncovalent inhibitor of phospho-p62/Keap1 interaction, which thus increases Keap1-induced Nrf2 degradation, showed an antineoplastic effect in HCC cell lines by decreasing proliferation and enhancing cytotoxicity of anti-cancer drugs.